In addition to binding PKA, AKAP17A has also been found to interact with the splicing factors ZNF265, ASF/SF2, and SC35, and therefore acts as a regulator of alternative splicing, which is often perturbed in cancer cells [84, 85]. This evidence concerns the gene SRSF1 and cancer.